Search

Search Results

1. Immunotherapy for Hepatocellular Carcinoma

   Background: Hepatocellular carcinoma (HCC), the most common primary malignancy of the liver, is the fifth most common cancer in men and seventh among...

   Vikrant Rai in Handbook of Cancer and Immunology

   Living reference work entry 2023
   

2. Liquid Biopsy in Hepatocellular Carcinoma

   Hepatocellular carcinoma (HCC) is one of the most deadly neoplasms with a poor prognosis. Due to the significant tumor heterogeneity of HCC,...

   Zheyu Zhou, **aoliang Xu, ... Yin Yin in Liquid Biopsies

   Protocol 2023
   

3. Orthotopic Model of Hepatocellular Carcinoma in Mice

   Orthotopic models of hepatocellular carcinoma (HCC) consist in the implantation of tumor cells into the liver by direct intrahepatic injection. In...

   Flavia Lambertucci, Si**g Li, ... Isabelle Martins in Liver Carcinogenesis

   Protocol 2024
   

4. DEN-Induced Hepatocellular Carcinoma in Animal Model

   Cancer is a major cause of death both in developed and develo** countries. Among the various types of cancers, primary liver cancer represents...

   K. Sivakumari, P. Janani, S. Rajesh in Handbook of Animal Models and its Uses in Cancer Research

   Reference work entry 2023
   

5. Synbiotics in Hepatocellular Carcinoma

   Cancer is a deadly disease that affect a wide range of population worldwide. It is accounting for nearly 10 million deaths in 2020, or nearly one in...

   Kuttiappan Anitha, Jamal Basha Dudekula, ... Shvetank Bhatt in Synbiotics for the Management of Cancer

   Chapter 2023
   

6. Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors

   Objective

   The predictive biomarkers of immune checkpoint inhibitors (ICIs) in hepatocellular carcinoma (HCC) still need to be further explored. This...

   Rujia Zhang, Haoran Zhao, ... Zhaowei Qu in BMC Cancer

   Article Open access 01 December 2023
   

7. Drug Resistance in Hepatocellular Carcinoma

   At present, the burden of cancer morbidity and mortality is increasing all over the world. Among all kinds of cancer, primary liver cancer is...

   **nxin Chen, ** Li, ... Chao Liang in Hepatobiliary Cancers: An Interdisciplinary Approach

   Chapter 2023
   

8. Fibrosis and Immunotherapy in Hepatocellular Carcinoma

   Hepatocellular carcinoma (HCC) is difficult-to-treat cancer, despite great advances in systemic therapy, with a median survival of 6–20 months, due...

   Sarah B. White, Dilip Rajasekhar Maddirela in Hepatobiliary Cancers: An Interdisciplinary Approach

   Chapter 2023
   

9. Interferon-induced transmembrane protein 3 in hepatocellular carcinoma patients

   Objective

   The study aimed to investigate the over expression of IFITM3 in hepatocellular carcinoma Egyptian patients.

   Background

   Hepatocellular...

   Rania M. Bondok, Lamiaa A. Barakat, ... Maivel H. Ghattas in BMC Cancer

   Article Open access 23 June 2023
   

10. Spatially resolved visualization of reprogrammed metabolism in hepatocellular carcinoma by mass spectrometry imaging

    Background

    Metabolic reprogramming refers to tumor-associated metabolic alterations during tumorigenesis and has been regarded as one of the most...

    Bangzhen Ma, Yang Zhang, ... Chengkun Qin in Cancer Cell International

    Article Open access 24 August 2023
    

11. Orientin regulates the proliferation and migration of hepatocellular carcinoma cells

    Orientin is a flavone isolated from medicinal plants used in traditional Chinese medicine (TCM) that suppresses the growth of cancer cells in vitro....

    Jia-Yi Tao, **g Li, ... Li-Peng Wan in Naunyn-Schmiedeberg's Archives of Pharmacology

    Article 13 May 2023
    

12. Hub gene identification and immune infiltration analysis in hepatocellular carcinoma: Computational approach

    In the case of hepatocellular carcinoma, there is a need to find novel immune biomarkers to predict cancer prognosis, which will help prolong patient...

    Swetha Pulakuntla, Shri Abhiav Singh, Vaddi Damodara Reddy in In Silico Pharmacology

    Article 06 May 2024
    

13. Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3

    Purpose

    The purpose of this study was to explore the expression and potential mechanism of hsa_circ_0005397 in hepatocellular carcinoma progression.

    ...

    Liu-**a Yuan, Mei Luo, ... Lin Chen in BMC Cancer

    Article Open access 21 February 2024
    

14. DEN-Induced Hepatocellular Carcinoma in Animal Model

    Cancer is a major cause of death both in developed and develo** countries. Among the various types of cancers, primary liver cancer represents...

    K. Sivakumari, P. Janani, S. Rajesh in Handbook of Animal Models and its Uses in Cancer Research

    Living reference work entry 2022
    

15. A Mouse Model of Hepatocellular Carcinoma Induced by Streptozotocin and High-Fat Diet

    Hepatocellular carcinoma (HCC) is the most common type of liver cancer and the second most common cause of cancer-related death. HCC is associated to...

    Omar Motiño, Si**g Li, ... Isabelle Martins in Liver Carcinogenesis

    Protocol 2024
    

16. Perspectives in Biochemical Staging of Hepatocellular Carcinoma Over the Current Microscopical Methodology

    Hepatocellular carcinoma (HCC) is considered the third main cause of cancer-related deaths globally. Comparing with other tumors, survival of HCC...

    Nabil Mohie Abdel-Hamid, Shimaa Ali Abass in Handbook of Cancer and Immunology

    Living reference work entry 2023
    

17. Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications

    Hepatocellular Carcinoma (HCC) is one of the most common types of primary liver cancer. Current treatment options have limited efficacy against this...

    Fatema Safri, Romario Nguyen, ... Liang Qiao in Cancer Gene Therapy

    Article Open access 18 March 2024
    

18. An overview of mouse models of hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) has become a severe burden on global health due to its high morbidity and mortality rates. However, effective...

    Hua-chuan Zheng, Hang Xue, Wen-**g Yun in Infectious Agents and Cancer

    Article Open access 05 September 2023
    

19. Deep dissection of stemness-related hierarchies in hepatocellular carcinoma

    Background

    Increasing evidence suggests that hepatocellular carcinoma (HCC) stem cells (LCSCs) play an essential part in HCC recurrence, metastasis,...

    Rui Liang, Weifeng Hong, ... Guanbin Song in Journal of Translational Medicine

    Article Open access 16 September 2023
    

20. G6PD and machine learning algorithms as prognostic and diagnostic indicators of liver hepatocellular carcinoma

    Background

    Liver Hepatocellular carcinoma (LIHC) exhibits a high incidence of liver cancer with escalating mortality rates over time. Despite this,...

    Fei Li, Boshen Wang, ... Baoli Zhu in BMC Cancer

    Article Open access 31 January 2024